{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:02:48Z","timestamp":1791471768630,"version":"4.3.4"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,20]],"date-time":"2024-04-20T00:00:00Z","timestamp":1713571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,20]],"date-time":"2024-04-20T00:00:00Z","timestamp":1713571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["Age-IT"],"award-info":[{"award-number":["Age-IT"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PE00000015"],"award-info":[{"award-number":["PE00000015"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PRIN 2022"],"award-info":[{"award-number":["PRIN 2022"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["2022AA37N3"],"award-info":[{"award-number":["2022AA37N3"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["CAL.HUB.RIA"],"award-info":[{"award-number":["CAL.HUB.RIA"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["T4-AN-09"],"award-info":[{"award-number":["T4-AN-09"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute of Cardiovascular Research","award":["The challenge of dealing with heart failure with preserved ejection fraction: multiple phenotypes with a common pathophysiological substratum?\u201d"],"award-info":[{"award-number":["The challenge of dealing with heart failure with preserved ejection fraction: multiple phenotypes with a common pathophysiological substratum?\u201d"]}]},{"name":"National Institute of Cardiovascular Research","award":["Donazione AnnaMaria Ruvinetti"],"award-info":[{"award-number":["Donazione AnnaMaria Ruvinetti"]}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PRIN 2022"],"award-info":[{"award-number":["PRIN 2022"]}],"id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["2022XXX2XC"],"award-info":[{"award-number":["2022XXX2XC"]}],"id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Maladaptive cardiac hypertrophy contributes to the development of heart failure (HF). The oxidoreductase Selenoprotein T (SELENOT) emerged as a key regulator during rat cardiogenesis and acute cardiac protection. However, its action in chronic settings of cardiac dysfunction is not understood. Here, we investigated the role of SELENOT in the pathophysiology of HF: (i) by designing a small peptide (PSELT), recapitulating SELENOT activity via the redox site, and assessed its beneficial action in a preclinical model of HF [aged spontaneously hypertensive heart failure (SHHF) rats] and against isoproterenol (ISO)-induced hypertrophy in rat ventricular H9c2 and adult human AC16 cardiomyocytes; (ii) by evaluating the SELENOT intra-cardiomyocyte production and secretion under hypertrophied stimulation. Results showed that PSELT attenuated systemic inflammation, lipopolysaccharide (LPS)-induced macrophage M1 polarization, myocardial injury, and the severe ultrastructural alterations, while counteracting key mediators of cardiac fibrosis, aging, and DNA damage and\u00a0restoring desmin downregulation and SELENOT upregulation in the failing hearts. In the hemodynamic assessment, PSELT improved the contractile impairment at baseline and following ischemia\/reperfusion injury, and reduced infarct size in normal and failing hearts. At cellular level, PSELT counteracted ISO-mediated hypertrophy and ultrastructural alterations through its redox motif, while mitigating ISO-triggered SELENOT intracellular production and secretion, a phenomenon that presumably reflects the extent of cell damage. Altogether, these results indicate that SELENOT could represent a novel sensor of hypertrophied cardiomyocytes and a potential PSELT-based new therapeutic approach in myocardial hypertrophy and HF.<\/jats:p>\n                <jats:p><jats:bold>Graphical Abstract<\/jats:bold><\/jats:p>","DOI":"10.1186\/s12967-024-05192-w","type":"journal-article","created":{"date-parts":[[2024,4,21]],"date-time":"2024-04-21T02:50:22Z","timestamp":1713667822000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["The redox-active defensive Selenoprotein T as a novel stress sensor protein playing a key role in the pathophysiology of heart failure"],"prefix":"10.1186","volume":"22","author":[{"given":"Anna","family":"De Bartolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Pasqua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Romeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittoria","family":"Rago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida","family":"Perrotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Concetta","family":"Granieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Marrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Mazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Carmela","family":"Cerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Lefranc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Leprince","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youssef","family":"Anouar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7797-7862","authenticated-orcid":false,"given":"Tommaso","family":"Angelone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmine","family":"Rocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,20]]},"reference":[{"key":"5192_CR1","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/ehf2.13144","volume":"8","author":"D Jen\u010da","year":"2021","unstructured":"Jen\u010da D, Melenovsk\u00fd V, Stehlik J, Stan\u011bk V, Kettner J, Kautzner J, et al. Heart failure after myocardial infarction: incidence and predictors. ESC Hear Fail. 2021;8:222\u201337. https:\/\/doi.org\/10.1002\/ehf2.13144.","journal-title":"ESC Hear Fail"},{"key":"5192_CR2","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1186\/s12967-021-02935-x","volume":"19","author":"Y Lin","year":"2021","unstructured":"Lin Y, Fu S, Yao Y, Li Y, Zhao Y, Luo L. Heart failure with preserved ejection fraction based on aging and comorbidities. J Transl Med. 2021;19:291. https:\/\/doi.org\/10.1186\/s12967-021-02935-x.","journal-title":"J Transl Med"},{"key":"5192_CR3","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1002\/ehf2.14363","volume":"10","author":"EA Jankowska","year":"2023","unstructured":"Jankowska EA, Andersson T, Kaiser-Albers C, Bozkurt B, Chioncel O, Coats AJS, et al. Optimizing outcomes in heart failure: 2022 and beyond. ESC Hear Fail. 2023;10:2159\u201369. https:\/\/doi.org\/10.1002\/ehf2.14363.","journal-title":"ESC Hear Fail"},{"key":"5192_CR4","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001123","author":"CW Tsao","year":"2023","unstructured":"Tsao CW, Aday AW, Almarzooq ZI, Anderson CA, Arora P, Avery CL, et al. Heart Disease and Stroke Statistics\u20142023 update: a report from the American Heart Association. Circulation. 2023. https:\/\/doi.org\/10.1161\/CIR.0000000000001123.","journal-title":"Circulation"},{"key":"5192_CR5","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1002\/ejhf.2212","volume":"23","author":"BA Mulder","year":"2021","unstructured":"Mulder BA, van Veldhuisen DJ, Rienstra M. Sudden cardiac death in heart failure: more than meets the eye. Eur J Heart Fail. 2021;23:1361\u20133. https:\/\/doi.org\/10.1002\/ejhf.2212.","journal-title":"Eur J Heart Fail"},{"key":"5192_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2022.107003","volume":"145","author":"T Pasqua","year":"2022","unstructured":"Pasqua T, Tropea T, Granieri MC, De Bartolo A, Spena A, Moccia F, et al. Novel molecular insights and potential approaches for targeting hypertrophic cardiomyopathy: focus on coronary modulators. Vasc Pharmacol. 2022;145: 107003.","journal-title":"Vasc Pharmacol"},{"key":"5192_CR7","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1186\/s12967-023-04498-5","volume":"21","author":"C Rocca","year":"2023","unstructured":"Rocca C, Soda T, De Francesco EM, Fiorillo M, Moccia F, Viglietto G, et al. Mitochondrial dysfunction at the crossroad of cardiovascular diseases and cancer. J Transl Med. 2023;21:635. https:\/\/doi.org\/10.1186\/s12967-023-04498-5.","journal-title":"J Transl Med"},{"key":"5192_CR8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12967-023-04820-1","volume":"22","author":"A Turkieh","year":"2024","unstructured":"Turkieh A, Beseme O, Saura O, Charrier H, Michel J-B, Amouyel P, et al. LIPCAR levels in plasma-derived extracellular vesicles is associated with left ventricle remodeling post-myocardial infarction. J Transl Med. 2024;22:31. https:\/\/doi.org\/10.1186\/s12967-023-04820-1.","journal-title":"J Transl Med"},{"key":"5192_CR9","doi-asserted-by":"publisher","first-page":"721","DOI":"10.3390\/jcm10040721","volume":"10","author":"T Pasqua","year":"2021","unstructured":"Pasqua T, Rocca C, Giglio A, Angelone T. Cardiometabolism as an interlocking puzzle between the healthy and diseased heart: new frontiers in therapeutic applications. J Clin Med. 2021;10:721.","journal-title":"J Clin Med"},{"issue":"Suppl 2","key":"5192_CR10","first-page":"7","volume":"91","author":"JGF Cleland","year":"2005","unstructured":"Cleland JGF, Torabi A, Khan NK. Epidemiology and management of heart failure and left ventricular systolic dysfunction in the aftermath of a myocardial infarction. Heart. 2005;91(Suppl 2):7\u201313 (discussion ii31, ii43-8).","journal-title":"Heart"},{"key":"5192_CR11","doi-asserted-by":"publisher","first-page":"4564","DOI":"10.3390\/jcm12144564","volume":"12","author":"C Rocca","year":"2023","unstructured":"Rocca C, Angelone T. Emerging molecular determinants and protective strategies in heart disease: what\u2019s new in the journal of clinical medicine? Outlook to the future. J Clin Med. 2023;12:4564.","journal-title":"J Clin Med"},{"key":"5192_CR12","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12967-017-1166-z","volume":"15","author":"T Baranyai","year":"2017","unstructured":"Baranyai T, Giricz Z, Varga ZV, Koncsos G, Lukovic D, Makkos A, et al. In vivo MRI and ex vivo histological assessment of the cardioprotection induced by ischemic preconditioning, postconditioning and remote conditioning in a closed-chest porcine model of reperfused acute myocardial infarction: importance of microvasculature. J Transl Med. 2017;15:67. https:\/\/doi.org\/10.1186\/s12967-017-1166-z.","journal-title":"J Transl Med"},{"key":"5192_CR13","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1161\/01.HYP.33.1.402","volume":"33","author":"KM Anderson","year":"1999","unstructured":"Anderson KM, Eckhart AD, Willette RN, Koch WJ. The Myocardial \u03b2-Adrenergic System in Spontaneously Hypertensive Heart Failure (SHHF) Rats. Hypertension. 1999;33:402\u20137. https:\/\/doi.org\/10.1161\/01.HYP.33.1.402.","journal-title":"Hypertension"},{"key":"5192_CR14","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1161\/01.HYP.29.3.715","volume":"29","author":"M Castellano","year":"1997","unstructured":"Castellano M, B\u00f6hm M. The cardiac \u03b2-adrenoceptor\u2013mediated signaling pathway and its alterations in hypertensive heart disease. Hypertension. 1997;29:715\u201322. https:\/\/doi.org\/10.1161\/01.HYP.29.3.715.","journal-title":"Hypertension"},{"key":"5192_CR15","doi-asserted-by":"publisher","first-page":"H103","DOI":"10.1152\/ajpheart.00069.2017","volume":"313","author":"LM Hanft","year":"2017","unstructured":"Hanft LM, Emter CA, McDonald KS. Cardiac myofibrillar contractile properties during the progression from hypertension to decompensated heart failure. Am J Physiol Circ Physiol. 2017;313:H103\u201313. https:\/\/doi.org\/10.1152\/ajpheart.00069.2017.","journal-title":"Am J Physiol Circ Physiol"},{"key":"5192_CR16","doi-asserted-by":"publisher","first-page":"6976","DOI":"10.1073\/pnas.1319022111","volume":"111","author":"F Li","year":"2014","unstructured":"Li F, Lutz PB, Pepelyayeva Y, Arn\u00e9r ESJ, Bayse CA, Rozovsky S. Redox active motifs in selenoproteins. Proc Natl Acad Sci USA. 2014;111:6976\u201381. https:\/\/doi.org\/10.1073\/pnas.1319022111.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5192_CR17","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.freeradbiomed.2018.05.076","volume":"127","author":"Y Anouar","year":"2018","unstructured":"Anouar Y, Lihrmann I, Falluel-Morel A, Boukhzar L. Selenoprotein T is a key player in ER proteostasis, endocrine homeostasis and neuroprotection. Free Radic Biol Med. 2018;127:145\u201352.","journal-title":"Free Radic Biol Med"},{"key":"5192_CR18","doi-asserted-by":"publisher","first-page":"3969","DOI":"10.1007\/s00018-019-03195-1","volume":"76","author":"C Rocca","year":"2019","unstructured":"Rocca C, Pasqua T, Boukhzar L, Anouar Y, Angelone T. Progress in the emerging role of selenoproteins in cardiovascular disease: focus on endoplasmic reticulum-resident selenoproteins. Cell Mol Life Sci. 2019;76:3969\u201385. https:\/\/doi.org\/10.1007\/s00018-019-03195-1.","journal-title":"Cell Mol Life Sci"},{"key":"5192_CR19","doi-asserted-by":"publisher","DOI":"10.1111\/apha.13067","author":"C Rocca","year":"2018","unstructured":"Rocca C, Boukhzar L, Granieri MC, Alsharif I, Mazza R, Lefranc B, et al. A selenoprotein T-derived peptide protects the heart against ischaemia reperfusion injury through inhibition of apoptosis and oxidative stress. Acta Physiol. 2018. https:\/\/doi.org\/10.1111\/apha.13067.","journal-title":"Acta Physiol"},{"key":"5192_CR20","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2023.0285","author":"T Angelone","year":"2024","unstructured":"Angelone T, Rocca C, Lionetti V, Penna C, Pagliaro P. Expanding the frontiers of guardian antioxidant selenoproteins in cardiovascular pathophysiology. Antioxid Redox Signal. 2024. https:\/\/doi.org\/10.1089\/ars.2023.0285.","journal-title":"Antioxid Redox Signal"},{"key":"5192_CR21","doi-asserted-by":"publisher","first-page":"571","DOI":"10.3390\/antiox11030571","volume":"11","author":"C Rocca","year":"2022","unstructured":"Rocca C, De Bartolo A, Granieri MC, Rago V, Amelio D, Falbo F, et al. The antioxidant selenoprotein T mimetic, PSELT, induces preconditioning-like myocardial protection by relieving endoplasmic-reticulum stress. Antioxidants. 2022;11:571.","journal-title":"Antioxidants"},{"key":"5192_CR22","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.3390\/cells12071042","volume":"12","author":"C Rocca","year":"2023","unstructured":"Rocca C, De Bartolo A, Guzzi R, Crocco MC, Rago V, Romeo N, et al. Palmitate-induced cardiac lipotoxicity is relieved by the redox-active motif of SELENOT through improving mitochondrial function and regulating metabolic state. Cells. 2023;12:1042.","journal-title":"Cells"},{"key":"5192_CR23","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.3390\/antiox10091427","volume":"10","author":"D Merk","year":"2021","unstructured":"Merk D, Ptok J, Jakobs P, von Ameln F, Greulich J, Kluge P, et al. Selenoprotein T protects endothelial cells against lipopolysaccharide-induced activation and apoptosis. Antioxidants. 2021;10:1427.","journal-title":"Antioxidants"},{"key":"5192_CR24","doi-asserted-by":"publisher","first-page":"H1775","DOI":"10.1152\/ajpheart.00305.2002","volume":"283","author":"JRR Heyen","year":"2002","unstructured":"Heyen JRR, Blasi ER, Nikula K, Rocha R, Daust HA, Frierdich G, et al. Structural, functional, and molecular characterization of the SHHF model of heart failure. Am J Physiol Circ Physiol. 2002;283:H1775\u201384. https:\/\/doi.org\/10.1152\/ajpheart.00305.2002.","journal-title":"Am J Physiol Circ Physiol"},{"key":"5192_CR25","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0008-6363(98)00076-5","volume":"39","author":"S Doggrell","year":"1998","unstructured":"Doggrell S, Brown L. Rat models of hypertension, cardiac hypertrophy and failure. Cardiovasc Res. 1998;39:89\u2013105. https:\/\/doi.org\/10.1016\/S0008-6363(98)00076-5.","journal-title":"Cardiovasc Res"},{"key":"5192_CR26","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/CCM.0b013e3182676352","volume":"41","author":"M Yashiro","year":"2013","unstructured":"Yashiro M, Tsukahara H, Matsukawa A, Yamada M, Fujii Y, Nagaoka Y, et al. Redox-active protein thioredoxin-1 administration ameliorates influenza A virus (H1N1)-induced acute lung injury in mice. Crit Care Med. 2013;41:171\u201381.","journal-title":"Crit Care Med"},{"key":"5192_CR27","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1177\/000456327200900102","volume":"9","author":"MJ McQueen","year":"1972","unstructured":"McQueen MJ. Optimal assay of LDH and \u03b1-HBD at 37 \u00b0C. Ann Clin Biochem Int J Lab Med. 1972;9:21\u20135. https:\/\/doi.org\/10.1177\/000456327200900102.","journal-title":"Ann Clin Biochem Int J Lab Med"},{"key":"5192_CR28","doi-asserted-by":"publisher","first-page":"7734","DOI":"10.1096\/fj.201802707R","volume":"33","author":"C Rocca","year":"2019","unstructured":"Rocca C, Scavello F, Colombo B, Gasparri AM, Dallatomasina A, Granieri MC, et al. Physiological levels of chromogranin A prevent doxorubicin-induced cardiotoxicity without impairing its anticancer activity. FASEB J. 2019;33:7734\u201347. https:\/\/doi.org\/10.1096\/fj.201802707R.","journal-title":"FASEB J"},{"key":"5192_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115542","volume":"257","author":"S Gastaldi","year":"2023","unstructured":"Gastaldi S, Rocca C, Gianquinto E, Granieri MC, Boscaro V, Blua F, et al. Discovery of a novel 1,3,4-oxadiazol-2-one-based NLRP3 inhibitor as a pharmacological agent to mitigate cardiac and metabolic complications in an experimental model of diet-induced metaflammation. Eur J Med Chem. 2023;257: 115542.","journal-title":"Eur J Med Chem"},{"key":"5192_CR30","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/978-1-61779-821-4_4","volume-title":"Protein solubilization: attend to the choice of lysis buffer","author":"M Peach","year":"2012","unstructured":"Peach M, Marsh N, MacPhee DJ. Protein solubilization: attend to the choice of lysis buffer. Totowa: Humana Press; 2012. p. 37\u201347. https:\/\/doi.org\/10.1007\/978-1-61779-821-4_4."},{"key":"5192_CR31","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/S0008-6363(02)00719-8","volume":"57","author":"GC Qun","year":"2003","unstructured":"Qun GC. Matrix metalloproteinase-2 mediates cytokine-induced myocardial contractile dysfunction. Cardiovasc Res. 2003;57:426\u201333. https:\/\/doi.org\/10.1016\/S0008-6363(02)00719-8.","journal-title":"Cardiovasc Res"},{"key":"5192_CR32","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.numecd.2009.10.011","volume":"21","author":"T Angelone","year":"2011","unstructured":"Angelone T, Pasqua T, Di Majo D, Quintieri AM, Filice E, Amodio N, et al. Distinct signalling mechanisms are involved in the dissimilar myocardial and coronary effects elicited by quercetin and myricetin, two red wine flavonols. Nutr Metab Cardiovasc Dis. 2011;21:362\u201371.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"5192_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2018.00521\/full","author":"C Rocca","year":"2018","unstructured":"Rocca C, Femmin\u00f2 S, Aquila G, Granieri MC, De Francesco EM, Pasqua T, et al. Notch1 mediates preconditioning protection induced by GPER in normotensive and hypertensive female rat hearts. Front Physiol. 2018. https:\/\/doi.org\/10.3389\/fphys.2018.00521\/full.","journal-title":"Front Physiol"},{"key":"5192_CR34","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1089\/ars.2020.8016","volume":"32","author":"C Rocca","year":"2020","unstructured":"Rocca C, Pasqua T, Cerra MC, Angelone T. Cardiac damage in anthracyclines therapy: focus on oxidative stress and inflammation. Antioxid Redox Signal. 2020;32:1081\u201397. https:\/\/doi.org\/10.1089\/ars.2020.8016.","journal-title":"Antioxid Redox Signal"},{"key":"5192_CR35","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.3390\/antiox9111066","volume":"9","author":"T Pasqua","year":"2020","unstructured":"Pasqua T, Rocca C, Lupi FR, Baldino N, Amelio D, Parisi OI, et al. Cardiac and metabolic impact of functional foods with antioxidant properties based on whey derived proteins enriched with hemp seed oil. Antioxidants. 2020;9:1066.","journal-title":"Antioxidants"},{"key":"5192_CR36","doi-asserted-by":"publisher","first-page":"5486","DOI":"10.3390\/app11125486","volume":"11","author":"F Grande","year":"2021","unstructured":"Grande F, De Bartolo A, Occhiuzzi MA, Caruso A, Rocca C, Pasqua T, et al. Carbazole and simplified derivatives: novel tools toward \u03b2-adrenergic receptors targeting. Appl Sci. 2021;11:5486.","journal-title":"Appl Sci"},{"key":"5192_CR37","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1111\/j.1440-1681.2010.05420.x","volume":"37","author":"J-L Liang","year":"2010","unstructured":"Liang J-L, Xiao D-Z, Liu X-Y, Lin Q-X, Shan Z-X, Zhu J-N, et al. High glucose induces apoptosis in AC16 human cardiomyocytes via macrophage migration inhibitory factor and c-Jun N-terminal kinase. Clin Exp Pharmacol Physiol. 2010;37:969\u201373.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"5192_CR38","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.yjmcc.2005.03.003","volume":"39","author":"M Davidson","year":"2005","unstructured":"Davidson M, Nesti C, Palenzuela L, Walker W, Hernandez E, Protas L, et al. Novel cell lines derived from adult human ventricular cardiomyocytes. J Mol Cell Cardiol. 2005;39:133\u201347.","journal-title":"J Mol Cell Cardiol"},{"key":"5192_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114857","volume":"163","author":"Z Mirsanei","year":"2023","unstructured":"Mirsanei Z, Heidari N, Hazrati A, Asemani Y, Niknam B, Yousefi Z, et al. Oleuropein reduces LPS-induced inflammation via stimulating M2 macrophage polarization. Biomed Pharmacother. 2023;163: 114857.","journal-title":"Biomed Pharmacother"},{"key":"5192_CR40","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.3390\/biomedicines11102666","volume":"11","author":"S Kang","year":"2023","unstructured":"Kang S, Wang B, Xie Y, Cao X, Wang M. The role of M1 and M2 myocardial macrophages in promoting proliferation and healing via activating epithelial-to-mesenchymal transition. Biomedicines. 2023;11:2666.","journal-title":"Biomedicines"},{"key":"5192_CR41","doi-asserted-by":"publisher","DOI":"10.1111\/apha.13570","author":"C Rocca","year":"2021","unstructured":"Rocca C, Grande F, Granieri MC, Colombo B, De Bartolo A, Giordano F, et al. The chromogranin A 1\u2013373 fragment reveals how a single change in the protein sequence exerts strong cardioregulatory effects by engaging neuropilin-1. Acta Physiol. 2021. https:\/\/doi.org\/10.1111\/apha.13570.","journal-title":"Acta Physiol."},{"key":"5192_CR42","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.vph.2013.02.004","volume":"58","author":"MMY Tse","year":"2013","unstructured":"Tse MMY, Aboutabl ME, Althurwi HN, Elshenawy OH, Abdelhamid G, El-Kadi AOS. Cytochrome P450 epoxygenase metabolite, 14,15-EET, protects against isoproterenol-induced cellular hypertrophy in H9c2 rat cell line. Vascul Pharmacol. 2013;58:363\u201373.","journal-title":"Vascul Pharmacol"},{"key":"5192_CR43","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1007\/s00394-021-02768-w","volume":"61","author":"X Qu","year":"2022","unstructured":"Qu X, Zhai B, Hu W, Lou M, Chen Y, Liu Y, et al. Pyrroloquinoline quinone ameliorates diabetic cardiomyopathy by inhibiting the pyroptosis signaling pathway in C57BL\/6 mice and AC16 cells. Eur J Nutr. 2022;61:1823\u201336. https:\/\/doi.org\/10.1007\/s00394-021-02768-w.","journal-title":"Eur J Nutr"},{"key":"5192_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107487","volume":"94","author":"C Rocca","year":"2021","unstructured":"Rocca C, De Bartolo A, Grande F, Rizzuti B, Pasqua T, Giordano F, et al. Cateslytin abrogates lipopolysaccharide-induced cardiomyocyte injury by reducing inflammation and oxidative stress through toll like receptor 4 interaction. Int Immunopharmacol. 2021;94: 107487.","journal-title":"Int Immunopharmacol"},{"key":"5192_CR45","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41440-022-01111-y","volume":"46","author":"H Zuo","year":"2023","unstructured":"Zuo H, Li L, Wang X, Chen S, Liao Z, Wei S, et al. A novel circ_0018553 protects against angiotensin-induced cardiac hypertrophy in cardiomyocytes by modulating the miR-4731\/SIRT2 signaling pathway. Hypertens Res. 2023;46:421\u201336.","journal-title":"Hypertens Res"},{"key":"5192_CR46","doi-asserted-by":"publisher","first-page":"3467","DOI":"10.1093\/cvr\/cvac187","volume":"118","author":"MS Khan","year":"2023","unstructured":"Khan MS, Shahid I, Greene SJ, Mentz RJ, DeVore AD, Butler J. Mechanisms of current therapeutic strategies for heart failure: more questions than answers? Cardiovasc Res. 2023;118:3467\u201381.","journal-title":"Cardiovasc Res"},{"key":"5192_CR47","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41569-019-0315-x","volume":"17","author":"L Adamo","year":"2020","unstructured":"Adamo L, Rocha-Resende C, Prabhu SD, Mann DL. Reappraising the role of inflammation in heart failure. Nat Rev Cardiol. 2020;17:269\u201385.","journal-title":"Nat Rev Cardiol"},{"key":"5192_CR48","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/1479-5876-7-67","volume":"7","author":"DE Lanfear","year":"2009","unstructured":"Lanfear DE, Hasan R, Gupta RC, Williams C, Czerska B, Tita C, et al. Short term effects of milrinone on biomarkers of necrosis, apoptosis, and inflammation in patients with severe heart failure. J Transl Med. 2009;7:67. https:\/\/doi.org\/10.1186\/1479-5876-7-67.","journal-title":"J Transl Med"},{"key":"5192_CR49","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/s12967-022-03466-9","volume":"20","author":"B Van Tassell","year":"2022","unstructured":"Van Tassell B, Mihalick V, Thomas G, Marawan A, Talasaz AH, Lu J, et al. Rationale and design of interleukin-1 blockade in recently decompensated heart failure (REDHART2): a randomized, double blind, placebo controlled, single center, phase 2 study. J Transl Med. 2022;20:270. https:\/\/doi.org\/10.1186\/s12967-022-03466-9.","journal-title":"J Transl Med"},{"key":"5192_CR50","doi-asserted-by":"publisher","first-page":"101839","DOI":"10.1016\/j.redox.2020.101839","volume":"40","author":"I Alsharif","year":"2021","unstructured":"Alsharif I, Boukhzar L, Lefranc B, Godefroy D, Aury-Landas J, Rego do JL, et al. Cell-penetrating, antioxidant SELENOT mimetic protects dopaminergic neurons and ameliorates motor dysfunction in Parkinson\u2019s disease animal models. Redox Biol. 2021;40:101839.","journal-title":"Redox Biol."},{"key":"5192_CR51","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1476-5381.2009.00057.x","volume":"157","author":"F Heitz","year":"2009","unstructured":"Heitz F, Morris MC, Divita G. Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics. Br J Pharmacol. 2009;157:195\u2013206. https:\/\/doi.org\/10.1111\/j.1476-5381.2009.00057.x.","journal-title":"Br J Pharmacol"},{"key":"5192_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/4375127","volume":"2020","author":"SE Duncan","year":"2020","unstructured":"Duncan SE, Gao S, Sarhene M, Coffie JW, Linhua D, Bao X, et al. Macrophage activities in myocardial infarction and heart failure. Cardiol Res Pract. 2020;2020:1\u201316.","journal-title":"Cardiol Res Pract"},{"key":"5192_CR53","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1165\/rcmb.2015-0012OC","volume":"53","author":"AA Tarique","year":"2015","unstructured":"Tarique AA, Logan J, Thomas E, Holt PG, Sly PD, Fantino E. Phenotypic, functional, and plasticity features of classical and alternatively activated human macrophages. Am J Respir Cell Mol Biol. 2015;53:676\u201388. https:\/\/doi.org\/10.1165\/rcmb.2015-0012OC.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"5192_CR54","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1093\/eurheartj\/ehy085","volume":"39","author":"L Wang","year":"2018","unstructured":"Wang L, Zhang Y-L, Lin Q-Y, Liu Y, Guan X-M, Ma X-L, et al. CXCL1\u2013CXCR2 axis mediates angiotensin II-induced cardiac hypertrophy and remodelling through regulation of monocyte infiltration. Eur Heart J. 2018;39:1818\u201331.","journal-title":"Eur Heart J"},{"key":"5192_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2024.167048","volume":"1870","author":"Q-Y Lin","year":"2024","unstructured":"Lin Q-Y, Yu W-J, Bai J, Jiang W-X, Li H-H. Mac-1 deficiency ameliorates pressure overloaded heart failure through inhibiting macrophage polarization and activation. Biochim Biophys Acta Mol Basis Dis. 2024;1870: 167048.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"5192_CR56","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/S1388-9842%2802%2900088-0","volume":"4","author":"C Piper","year":"2002","unstructured":"Piper C, Horstkotte D, Bock A, Wudel E, Schulthei\u00df H, D\u00f6rner A. Myocardial lactate dehydrogenase patterns in volume or pressure overloaded left ventricles. Eur J Heart Fail. 2002;4:587\u201391. https:\/\/doi.org\/10.1016\/S1388-9842%2802%2900088-0.","journal-title":"Eur J Heart Fail"},{"key":"5192_CR57","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000490","author":"SL Chow","year":"2017","unstructured":"Chow SL, Maisel AS, Anand I, Bozkurt B, de Boer RA, Felker GM, et al. Role of biomarkers for the prevention, assessment, and management of heart failure: a scientific statement from the American heart association. Circulation. 2017. https:\/\/doi.org\/10.1161\/CIR.0000000000000490.","journal-title":"Circulation."},{"key":"5192_CR58","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1093\/eurjhf\/hfp097","volume":"11","author":"RA de Boer","year":"2009","unstructured":"de Boer RA, Voors AA, Muntendam P, van Gilst WH, van Veldhuisen DJ. Galectin-3: a novel mediator of heart failure development and progression. Eur J Heart Fail. 2009;11:811\u20137. https:\/\/doi.org\/10.1093\/eurjhf\/hfp097.","journal-title":"Eur J Heart Fail"},{"key":"5192_CR59","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.jacc.2006.03.061","volume":"48","author":"RR van Kimmenade","year":"2006","unstructured":"van Kimmenade RR, Januzzi JL, Ellinor PT, Sharma UC, Bakker JA, Low AF, et al. Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure. J Am Coll Cardiol. 2006;48:1217\u201324.","journal-title":"J Am Coll Cardiol"},{"key":"5192_CR60","doi-asserted-by":"publisher","first-page":"H1220","DOI":"10.1152\/ajpheart.00601.2011","volume":"301","author":"PM McLendon","year":"2011","unstructured":"McLendon PM, Robbins J. Desmin-related cardiomyopathy: an unfolding story. Am J Physiol Circ Physiol. 2011;301:H1220\u20138. https:\/\/doi.org\/10.1152\/ajpheart.00601.2011.","journal-title":"Am J Physiol Circ Physiol"},{"key":"5192_CR61","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s41420-021-00549-2","volume":"7","author":"M Bouvet","year":"2021","unstructured":"Bouvet M, Dubois-Deruy E, Turkieh A, Mulder P, Peugnet V, Chwastyniak M, et al. Desmin aggrephagy in rat and human ischemic heart failure through PKC\u03b6 and GSK3\u03b2 as upstream signaling pathways. Cell Death Discov. 2021;7:153.","journal-title":"Cell Death Discov"},{"key":"5192_CR62","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.bbrep.2016.02.014","volume":"6","author":"M Bouvet","year":"2016","unstructured":"Bouvet M, Dubois-Deruy E, Alayi TD, Mulder P, El Amranii M, Beseme O, et al. Increased level of phosphorylated desmin and its degradation products in heart failure. Biochem Biophys Reports. 2016;6:54\u201362.","journal-title":"Biochem Biophys Reports"},{"key":"5192_CR63","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2018100492","author":"R Anderson","year":"2019","unstructured":"Anderson R, Lagnado A, Maggiorani D, Walaszczyk A, Dookun E, Chapman J, et al. Length-independent telomere damage drives post-mitotic cardiomyocyte senescence. EMBO J. 2019. https:\/\/doi.org\/10.15252\/embj.2018100492.","journal-title":"EMBO J."},{"key":"5192_CR64","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1186\/s12967-023-04361-7","volume":"21","author":"Q Yan","year":"2023","unstructured":"Yan Q, Liu S, Sun Y, Chen C, Yang S, Lin M, et al. Targeting oxidative stress as a preventive and therapeutic approach for cardiovascular disease. J Transl Med. 2023;21:519. https:\/\/doi.org\/10.1186\/s12967-023-04361-7.","journal-title":"J Transl Med"},{"key":"5192_CR65","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1016\/S1071-9164(03)00292-6","volume":"9","author":"LA Nikolaidis","year":"2003","unstructured":"Nikolaidis LA, Poornima I, Sokos G, Stolarski C, Shannon RP. The synergistic effects of aging and heart failure on myocardial insulin signaling in SHHF rats. J Card Fail. 2003;9:S15.","journal-title":"J Card Fail"},{"key":"5192_CR66","doi-asserted-by":"publisher","first-page":"920","DOI":"10.3390\/ph15080920","volume":"15","author":"PR Gon\u00e7alves","year":"2022","unstructured":"Gon\u00e7alves PR, Nascimento LD, Gerlach RF, Rodrigues KE, Prado AF. Matrix metalloproteinase 2 as a pharmacological target in heart failure. Pharmaceuticals. 2022;15:920.","journal-title":"Pharmaceuticals"},{"key":"5192_CR67","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.cardfail.2013.01.013","volume":"19","author":"YE Koshman","year":"2013","unstructured":"Koshman YE, Patel N, Chu M, Iyengar R, Kim T, Ersahin C, et al. Regulation of connective tissue growth factor gene expression and fibrosis in human heart failure. J Card Fail. 2013;19:283\u201394.","journal-title":"J Card Fail"},{"key":"5192_CR68","doi-asserted-by":"publisher","first-page":"17007","DOI":"10.1038\/srep17007","volume":"5","author":"C-K Wu","year":"2015","unstructured":"Wu C-K, Su M-Y, Lee J-K, Chiang F-T, Hwang J-J, Lin J-L, et al. Galectin-3 level and the severity of cardiac diastolic dysfunction using cellular and animal models and clinical indices. Sci Rep. 2015;5:17007.","journal-title":"Sci Rep"},{"key":"5192_CR69","doi-asserted-by":"publisher","first-page":"103","DOI":"10.14336\/AD.2021.0927","volume":"13","author":"C Hu","year":"2022","unstructured":"Hu C, Zhang X, Teng T, Ma Z-G, Tang Q-Z. Cellular senescence in cardiovascular diseases: a systematic review. Aging Dis. 2022;13:103.","journal-title":"Aging Dis"},{"key":"5192_CR70","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1038\/nrc2523","volume":"8","author":"WM Bonner","year":"2008","unstructured":"Bonner WM, Redon CE, Dickey JS, Nakamura AJ, Sedelnikova OA, Solier S, et al. \u03b3H2AX and cancer. Nat Rev Cancer. 2008;8:957\u201367.","journal-title":"Nat Rev Cancer"},{"key":"5192_CR71","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.jacbts.2018.11.011","volume":"4","author":"T Takahashi","year":"2019","unstructured":"Takahashi T, Shishido T, Kinoshita D, Watanabe K, Toshima T, Sugai T, et al. Cardiac nuclear high-mobility group box 1 ameliorates pathological cardiac hypertrophy by inhibiting DNA damage response. JACC Basic Transl Sci. 2019;4:234\u201347.","journal-title":"JACC Basic Transl Sci"},{"key":"5192_CR72","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1161\/CIRCULATIONAHA.118.034822","volume":"139","author":"Y Nakada","year":"2019","unstructured":"Nakada Y, Nhi Nguyen NU, Xiao F, Savla JJ, Lam NT, Abdisalaam S, et al. DNA damage response mediates pressure overload-induced cardiomyocyte hypertrophy. Circulation. 2019;139:1237\u20139. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.034822.","journal-title":"Circulation"},{"key":"5192_CR73","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1042\/BJ20070929","volume":"407","author":"H-Y Kim","year":"2007","unstructured":"Kim H-Y, Gladyshev VN. Methionine sulfoxide reductases: selenoprotein forms and roles in antioxidant protein repair in mammals. Biochem J. 2007;407:321\u20139.","journal-title":"Biochem J"},{"key":"5192_CR74","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.abb.2011.05.007","volume":"512","author":"FW Hoffmann","year":"2011","unstructured":"Hoffmann FW, Hashimoto AS, Lee BC, Rose AH, Shohet RV, Hoffmann PR. Specific antioxidant selenoproteins are induced in the heart during hypertrophy. Arch Biochem Biophys. 2011;512:38\u201344.","journal-title":"Arch Biochem Biophys"},{"key":"5192_CR75","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1161\/01.CIR.0000164237.58200.5A","volume":"111","author":"C Freund","year":"2005","unstructured":"Freund C, Schmidt-Ullrich R, Baurand A, Dunger S, Schneider W, Loser P, et al. Requirement of nuclear factor-\u03baB in angiotensin II\u2013 and isoproterenol-induced cardiac hypertrophy in vivo. Circulation. 2005;111:2319\u201325. https:\/\/doi.org\/10.1161\/01.CIR.0000164237.58200.5A.","journal-title":"Circulation"},{"key":"5192_CR76","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0248933","volume":"16","author":"SM Werhahn","year":"2021","unstructured":"Werhahn SM, Kreusser JS, Hagenm\u00fcller M, Beckendorf J, Diemert N, Hoffmann S, et al. Adaptive versus maladaptive cardiac remodelling in response to sustained \u03b2-adrenergic stimulation in a new \u2018ISO on\/off model.\u2019 PLoS ONE. 2021;16: e0248933. https:\/\/doi.org\/10.1371\/journal.pone.0248933.","journal-title":"PLoS ONE."},{"key":"5192_CR77","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/1479-5876-11-130","volume":"11","author":"D Chowdhury","year":"2013","unstructured":"Chowdhury D, Tangutur AD, Khatua TN, Saxena P, Banerjee SK, Bhadra MP. A proteomic view of isoproterenol induced cardiac hypertrophy: prohibitin identified as a potential biomarker in rats. J Transl Med. 2013;11:130. https:\/\/doi.org\/10.1186\/1479-5876-11-130.","journal-title":"J Transl Med"},{"key":"5192_CR78","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1016\/j.bbadis.2013.07.003","volume":"1832","author":"IA Sergeeva","year":"2013","unstructured":"Sergeeva IA, Christoffels VM. Regulation of expression of atrial and brain natriuretic peptide, biomarkers for heart development and disease. Biochim Biophys Acta - Mol Basis Dis. 2013;1832:2403\u201313.","journal-title":"Biochim Biophys Acta - Mol Basis Dis"},{"key":"5192_CR79","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1186\/s12967-023-04537-1","volume":"21","author":"L Scisciola","year":"2023","unstructured":"Scisciola L, Chianese U, Caponigro V, Basilicata MG, Salviati E, Altucci L, et al. Multi-omics analysis reveals attenuation of cellular stress by empagliflozin in high glucose-treated human cardiomyocytes. J Transl Med. 2023;21:662. https:\/\/doi.org\/10.1186\/s12967-023-04537-1.","journal-title":"J Transl Med"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05192-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-024-05192-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05192-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,21]],"date-time":"2024-04-21T02:51:56Z","timestamp":1713667916000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-024-05192-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,20]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5192"],"URL":"https:\/\/doi.org\/10.1186\/s12967-024-05192-w","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,20]]},"assertion":[{"value":"27 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal procedures were approved by the Institutional Review Board of the University of Calabria (UNICAL) and the Italian Ministry of Health, Rome, Italy and conducted in conformity with the guidelines from Legislative Decree n\u00b026\/2014 of Italian Ministry of Health, Directive 2010\/63\/EU of the European Parliament on the protection of animals used for scientific purposes.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"375"}}